CMS Increases Medicare Payment for the Minder System CY 2027
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Epiminder Ltd. has announced that the Centers for Medicare & Medicaid Services has finalized the payment rate for the Minder System implant procedure for the upcoming year, which is a significant increase from the previous rate. This new payment rate will provide hospitals with a predictable reimbursement when performing the Minder procedure in an outpatient setting, effective from the start of the year. The announcement highlights the importance of this payment determination for the company's commercial launch in the US market, particularly for hospitals considering new technologies. The filing emphasizes the positive momentum for Epiminder, including recent FDA clearance and ongoing clinical studies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Epiminder
- Resignation of Chief Financial Officer
- Change of Address
- Results of Annual General Meeting
- Minder System Cleared for Patients 12 -75 Years of Age
- FY27 YTD operational update and AGM materials
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder